The researchers found that RA608 treatment significantly reduced arrhythmia incidence and improved overall cardiac function, highlighting the potential of CaMKII inhibitors as a therapeutic strategy for heart failure patients [91]. Here, CAMK2G is linked to Arrhythmia.